PANews reported on November 17th that, according to Jinshi, cryptocurrency-related stocks in the US rose in pre-market trading after Bitcoin and Ethereum prices increased. Riot Platforms (RIOT.O) rose 0.6%, Hut 8 Mining rose 2.5%, and Mara Holdings rose 1.4%. Coinbase (COIN.O) rose 1%, Bitfarms rose 2.3%, and Strategy rose 1.4%. PROSHARES Bitcoin Strategy ETF rose 1.6%, and iShares Bitcoin Trust rose 1.5%.PANews reported on November 17th that, according to Jinshi, cryptocurrency-related stocks in the US rose in pre-market trading after Bitcoin and Ethereum prices increased. Riot Platforms (RIOT.O) rose 0.6%, Hut 8 Mining rose 2.5%, and Mara Holdings rose 1.4%. Coinbase (COIN.O) rose 1%, Bitfarms rose 2.3%, and Strategy rose 1.4%. PROSHARES Bitcoin Strategy ETF rose 1.6%, and iShares Bitcoin Trust rose 1.5%.

US cryptocurrency-related stocks rose in pre-market trading: Coinbase rose 1%, and Strategy rose 1.4%.

2025/11/17 17:50

PANews reported on November 17th that, according to Jinshi, cryptocurrency-related stocks in the US rose in pre-market trading after Bitcoin and Ethereum prices increased. Riot Platforms (RIOT.O) rose 0.6%, Hut 8 Mining rose 2.5%, and Mara Holdings rose 1.4%. Coinbase (COIN.O) rose 1%, Bitfarms rose 2.3%, and Strategy rose 1.4%. PROSHARES Bitcoin Strategy ETF rose 1.6%, and iShares Bitcoin Trust rose 1.5%.

Market Opportunity
Oasis Logo
Oasis Price(ROSE)
$0.01396
$0.01396$0.01396
+1.74%
USD
Oasis (ROSE) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.